Comparing 2 funds
Returns, costs and exposure side by side, with sources and dates below.
Ultra Nasdaq Biotechnology
Performance, starting at 100
If you had invested £10,000
Based on month end returns. Illustrative, before tax, not a prediction.
Country exposure
Not available for: Ultra Bloomberg Crude Oil.
Sector exposure
Not available for: Ultra Bloomberg Crude Oil.
AI comparison
Side by side
| Metric | Ultra Bloomberg Crude Oil | BIB |
|---|---|---|
| 1 year returnHighest in bold | ▲ +141.4% | ▲ +96.6% |
| 3 year returnHighest in bold | ▲ +39.0% | ▲ +126.6% |
| 5 year returnHighest in bold | ▲ +156.3% | ▲ +26.9% |
| Rank among sector peers, 1 yearQuartile among representative funds in the FE sector | Q1 of 486 representative funds | Q1 of 151 representative funds |
| Ongoing charge (OCF) | ||
| Fund size, GBPLargest in bold | n/a | n/a |
| Volatility, 1 year FE, as at 30 Sep 2026 | 71.7% | 38.1% |
| Sharpe ratio, 1 year FE, as at 30 Sep 2026 | n/a | n/a |
| Style | n/a | n/a |
| FE sector | n/a | n/a |
| Share class | USD | USD |
Source: FE fundinfo, as supplied; the date shown is when FE last updated them.